Report of an early stopped randomized trial comparing cisplatin vs. cisplatin/ifosfamide/5-fluorouracil in recurrent cervical cancer

Gynecologic and Obstetric Investigation

Volumn 59, Issue 3, 2005, Pages 126-129

  Cadron, Isabelle ^a   Jakobsen, Anders ^b   Vergote, Ignace ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Department of Oncology   (Denmark)

Author keywords

5 Fluorouracil; Cervical cancer; Cisplatin; Ifosfamide; Recurrent

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; FOLINIC ACID; IFOSFAMIDE; MESNA;

ADULT; AGED; ARTICLE; BONE MARROW TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; HEMATOLOGIC DISEASE; HUMAN; LEUKOPENIA; MONOTHERAPY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT CANCER; SIDE EFFECT; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; FEMALE; FLUOROURACIL; HUMANS; IFOSFAMIDE; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; REMISSION INDUCTION; UTERINE CERVICAL NEOPLASMS;

EID: 17844381617     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082750     Document Type: Article

References (16)

1. Bonomi P, Blessing JA, Stehman FB, Di Saia PJ, Walton L, Major FJ: Randomised trial of three cisplatin dose schedules in squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. J Clin Oncol 1985;3:1079-1085.
2. Blackledge G, Buxton EJ, Mould JJ, Monaghan J, Paterson M, Tobias J, Alcock C, Spooner D, Meanwel CA: Phase II studies of ifosfamide alone and in combination in cancer of the cervix. Cancer Chemother Pharmacol 1990; 26(suppl):S12-S16.
3. Thigpen T, Vance R, Khansur T, Malamud F: The role of ifosfamide and systemic therapy in the management of cancer of the cervix. Semin Oncol 1996;23(3 suppl 6):56-64.
4. Sutton GP, Blessing JA, Photopoulos G, Berman ML, Homesley HD: Phase II experience with ifosfamide/mesna in gynaecologic malignancies: Preliminary report of Gynecologic Oncology Group studies. Semin Oncol 1989; 16(suppl 3):68-72.
5. Malkasian GD, Decker DG, Mussey E, Johnson CE: Chemotherapy of squamous cell carcinoma of the cervix, vagina and vulva. Clin Obstet Gynec 1968;11:367-381.
6. Kaern J, Tropé C, Abeler V, Iversen T, Kjorstad K: A phase II study of 5-fluorouracil and cisplatin in recurrent cervical cancer. Acta Oncol 1990;29:25-28.
7. Stornes I, Mejlholm I, Jakobsen A: A phase II trial of ifosfamide, 5-fluorouracil and leucovorin in recurrent uterine cervical cancer. Gynecol Oncol 1994;55:123-125.
8. Fanning J, Ladd Ch, Hilgers RD: Cisplatin, 5-fluorouracil and ifosfamide in the treatment of recurrent or advanced cervical cancer. Gynecol Oncol 1995;56:235-238.
9. Guthrie D: Chemotherapy of cervical cancer. Clin Obstet Gynecol 1985;12:229-246.
10. Freedman RS, Herson J, Wharton JT, Rutledge FN: Single-agent chemotherapy for recurrent carcinoma of the cervix. Cancer Clin Trials 1980;3:345-350.
11. Vermorken JB: The role of chemotherapy in squamous cell carcinoma of the uterine cervix: A review. Int J Gynecol Cancer 1993;3:129-142.
12. Kaern J, Tropé C, Sundfoer K, Kristensen GB: Cisplatin/5- fluorouracil treatment of recurrent cervical carcinoma: A phase II study with long-term follow-up. Gynecol Oncol 1996;60:387-392.
13. Ramm K, Vergote IB, Kaern J, Tropé CG: Bleomycin-ifosfamide-cis- platinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: A second look. Gynecol Oncol 1992;46:203-207.
14. Blackledge G, Buxton EJ, Mould JJ, Monaghan J, Paterson M, Tobias J, Alcock C, Spooner D, Meanwel CA: Phase II studies of ifosfamide alone and in combination in cancer of the cervix. Cancer Chemother Pharmacol 1990; 26(suppl):12-16.
15. Buxton EJ, Meanwell CA, Hilton C, Mould JJ, Spooner D, Chetiyawardana A, Latief T, Paterson M, Redman CW, Luesley DM, Blackledge GR: Combination bleomycin, ifosfamide and cisplatin chemotherapy in cervical cancer. J Natl Cancer Inst 189;81:359-361.
16. Bloss JD, Blessing JA, Behrens BC, Mannel RS, Rader JS, Sood AK, Markman M, Benda J: Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: A Gynecologic Oncology Group study. J Clin Oncol 2002;20:1832-1837.